Secreted cathepsin L generates endostatin from collagen XVIII

EMBO Journal

Volumn 19, Issue 6, 2000, Pages 1187-1194

  Felbor, Ute ^a   Dreier, Lars ^a   Bryant, Rebecca A R ^a   Ploegh, Hidde L ^a   Olsen, Bjorn R ^a   Mothes, Walther ^b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cathepsin L; Collagen XVIII; Endostatin; LHVS; Metalloproteases

Indexed keywords

CATHEPSIN L; COLLAGEN; COLLAGEN XVIII; ENDOSTATIN; METALLOPROTEINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; HEMANGIOENDOTHELIOMA; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; TUMOR CELL; TUMOR GROWTH;

ANIMALIA; MURINAE;

EID: 0034653421     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.6.1187     Document Type: Article

References (41)

1. Aimes, R.T. and Quigley, J.P. (1995) Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J. Biol. Chem., 270, 5872-5876.
2. Brooks, P.C., Silletti, S., von Schalscha, T.L., Friedlander, M. and Cheresh, D.A. (1998) Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell, 92, 391-400.
3. Brown, P.D. and Whittaker, M. (1999) Matrix metalloproteinase inhibitors. In Teicher, B.A. (ed.), Antiangiogenic Agents in Cancer Therapy. Human Press, Totowa, NJ, pp. 205-223.
4. Clapp, C., Martial, J.A., Guzman, R.C., Rentier-Delrue, F. and Weiner, R.I. (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology, 133, 1292-1299.
5. Delaissé, J.M., Ledern, P. and Vaes, G. (1991) Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70 kDa proteinase. Biochem. J., 279, 167-174.
6. Dong, Z., Kumar, R., Yang, X. and Fidler, I.J. (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell, 88, 801-810.
7. Driessen, C., Bryant, R.A.R., Lennon-Dumenil, A.-M., Villadangos, J.A., Bryant, P.W., Shi, G.-P., Chapman, H.A. and Ploegh, H.L. (1999) Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J. Cell Biol., 147, 775-790.
8. Gamero, P., Borel, O., Byrjalsen, I., Ferreras, M., Drake, F.H., McQueney, M.S., Foged, N.T., Delmas, P.D. and Delaissé, J.-M. (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J. Biol. Chem., 273, 32347-32352.
9. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am. J. Physiol., 267, C195-C203.
10. Gupta, S.K., Hassel, T. and Singh, J.P. (1995) A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proc. Natl Acad. Sci. USA, 92, 7799-7803.
11. Halfter, W., Dong, S., Schurer, B. and Cole, G.J. (1998) Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem., 273, 25404-25412.
12. Hoak, J.C., Warner, E.D., Cheng, H.F., Fry, G.L. and Hankenson, R.R. (1971) Hemangioma with thrombocytopenia and microangiopathic anemia (Kasabach-Merritt syndrome): an animal model. J. Lab. Clin. Med., 77, 941-950.
13. Homandberg, G.A., Williams, J.E., Grant, D., Schumacher, B. and Eisenstein, R. (1985) Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am. J. Pathol., 120, 327-332.
14. Kafienah, W., Buttle, D.J., Burnett, D. and Hollander, A.P. (1998) Cleavage of native type I collagen by human neutrophil elastase. Biochem. J., 330, 897-902.
15. Kirschke, H. (1998) Cathepsin L. In Barrett, A.J., Rawlings, N.D. and Woessner, J.F. (eds), Handbook of Proteolytic Enzymes. Academic Press, San Diego, CA, pp. 617-621.
16. Kohfeldt, E., Maurer, P., Vannahme, C. and Timpl, R. (1997) Properties of the extracellular calcium binding module of the proteoglycan testican. FEBS Lett., 414, 557-561.
17. Kolkhorst, V., Stürzebecher, J. and Wiederanders, B. (1998) Inhibition of tumor cell invasion by protease inhibitors: correlation with the protease profile. J. Cancer Res. Clin. Oncol., 124, 598-606.
18. Kos, J. and Lah, T.T. (1998) Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer. Oncol. Rep., 5, 1349-1361.
19. Liotta, L.A., Steeg, P.S. and Stetler-Stevenson, W.G. (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336.
20. Maciewicz, R.A. and Etherington, D.J. (1988) A comparison of four cathepsins (B, L, N and S) with collagenolytic activity from rabbit spleen. Biochem. J., 256, 433-440.
21. Martínez-Zaguilán, R. (1999) Angiostatin's partners. Science, 284, 433-434.
22. Mason, R.W. and Mason, S.D. (1992) Surface activation of procathepsin L. Biochem. Biophys. Res. Commun., 189, 1659-1666.
23. Mason, R.W., Gal, S. and Gottesman, M.M. (1987) The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L. Biochem. J., 248, 449-454.
24. Miosge, N., Sasaki, T. and Timpl, R. (1999) Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls. FASEB J., 13, 1743-1750.
25. Moser, T.L., Stack, M.S., Asplin, I., Enghild, J.J., Højrup, P., Everitt, L., Hubchak, S., Schnaper, H.W. and Pizzo, S.V. (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl Acad. Sci. USA, 96, 2811-2816.
26. Motamed, K. and Sage, E.H. (1997) Regulation of vascular morphogenesis by the matricellular protein SPARC. Kidney Int., 51, 1383-1387.
27. Muragaki, Y., Timmons, S., Griffith, C.M., Oh, S.P., Fadel, B., Quertermous, T. and Olsen, B.R. (1995) Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc. Natl Acad. Sci. USA, 92, 8763-8767.
28. O'Reilly, M.S. et al. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79, 315-328.
29. O'Reilly, M.S. et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-285.
30. O'Reilly, M.S., Pirie-Shepherd, S., Lane, W.S. and Folkman, J. (1999) Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science, 285, 1926-1928.
31. Obeso, J., Weber, J. and Auerbach, R. (1990) A hemangioendothelioma-derived cell line: its use as a model for the study of endothelial cell biology. Lab. Invest., 63, 259-269.
32. Oh, S.P., Kamagata, Y., Muragaki, Y., Timmons, S., Ooshima, A. and Olsen, B.R. (1994) Isolation and sequencing of cDNAs for proteins with multiple domains of Gly-X-Y repeats identify a novel family of collagenous proteins. Proc. Natl Acad. Sci. USA, 91, 4229-4233.
33. Palmer, J.T., Rasnick, D., Klaus, J.L. and Bromme, D. (1995) Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem., 38, 3193-3196.
34. Rehn, M. and Pihlajaniemi, T. (1994) α1 (XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution and homology with type XV collagen. Proc. Natl Acad. Sci. USA, 91, 4234-4238.
35. Riese, R.J., Wolf, P.R., Brömme, D., Natkin, L.R., Villadangos, J.A., Ploegh, H.L. and Chapman, H.A. (1996) Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity, 4, 357-366.
36. Saarela, J., Rehn, M., Oikarinen, A., Autio-Harmainen, H. and Pihlajaniemi, T. (1998) The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am. J. Pathol., 153, 611-626.
37. Sasaki, T., Fukai, N., Mann, K., Göhring, W., Olsen, B.R. and Timpl, R. (1998) Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J., 17, 4249-4256.
38. Ständker, L., Schrader, M., Kanse, S.M., Jürgens, M., Forssman, W.-G. and Preissner, K.T. (1997) Isolation and characterization of the circulating form of human endostatin. FEBS Lett., 420, 129-133.
39. Starkey, P.M. (1977) The effect of human neutrophil elastase and cathepsin G on the collagen of cartilage, tendon and cornea. Acta Biol. Med. Ger., 36, 1549-1554.
40. Warburg, O. (1926) Ueber den Stoffwechsel der Tumoren. Cambridge University Press, Cambridge, UK.
41. Yamaguchi, N. et al. (1999) Endos tatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J., 18, 4414-4423.